CDER To Launch Application Review Pilot On Data Sharing In FY 2008
This article was originally published in The Pink Sheet Daily
Executive Summary
One BLA and one NME will be selected by the agency for pilot review before year-end, says CDER Office of New Drugs official.
You may also be interested in...
FDA’s Post-market Safety Reviews Of NMEs Find Timing May Not Be Everything
Initial results from pilot show drugs marketed for longer offer more telling data for safety recommendations, but the number of treated patients also may be a factor.
FDA’s Post-market Safety Reviews Of NMEs Find Timing May Not Be Everything
Initial results from pilot show drugs marketed for longer offer more telling data for safety recommendations, but the number of treated patients also may be a factor.
Compromise FDA Reform Bill Passes House, Adds $225 Million In User Fees For Drug Safety
Legislation requires patient summary of clinical trial results, but only if it can be written without being promotional.